Monthly Archives: April 2010

Do You Have a Head of Social Media?

And do you need one? Julian Upton looks at some of the contrasting ideas that emerged from last month’s Digital Pharma Europe event. If anyone had any lingering doubts about an unprecedented era of inclusion and transparency promised by pharma’s newfound, if tentative, embrace of online social media, then last month’s Digital Pharma Europe conference […]
Posted in E-Media, Europe, Events, Guest Blog, Strategy, Technology | Tagged , , , , , | 1 Comment

Huckabee and Johnston Expound on Reform

Image via Wikipedia Data analytics firm SAS, last week, played host to a bevy of pharma executives at the company’s Health Care & Life Sciences Executive Conference. The highlight, however, was a duel keynote speech from former Arkansas Governor Mike Huckabee and his sparring partner, former Massachusetts director of health and human services Philip Johnston. […]
Posted in Strategy | Tagged , , , , , , , , | 6 Comments

Patient Adherence Awards Winners Revealed

Image via Wikipedia The Center for Business Intelligence, on Monday, revealed winners of its annual Strategic Patient Adherence Awards as part of its two-day conference about patient compliance with their drug regiments. This year’s award winners are: Best Integrated Program—Shire Pharmaceuticals: FOSRENOL ON TRACK Direct To Patient Support Program Best Disease State Program—BMS/Sanofi-Aventis Canada & […]
Posted in Events, Strategy | Tagged , , , , , , , , , | Leave a comment

Government to Launch Academic Detailing Program

Some of the $1.1 billion in funding for Comparative Effectiveness Research (CER) provided by last year’s economic stimulus legislation will be used to support a major doctor education campaign on drugs and medical products and procedures. The Agency for Healthcare Research and Quality (AHRQ) plans to contract this fall with a marketing or advertising company […]
Posted in Medical Education, News, Sales, Strategy | Tagged , , , | 2 Comments

Lower Lilly Earnings the Shape of Things to Come

Eli Lilly announced its first quarter financial results on April 19. But even though the company trumpeted a global revenue growth rate of 9 percent—$5.49 billion, compared to Q1 2009’s $5.05 billion—net income fell 5 percent to $1.25 billion. Part of the blame for that 4 percent difference, the company said, lies with the passage […]
Posted in Strategy | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta